Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
What Is Bullous Keratopathy and How to Manage It
What Is Bullous Keratopathy? Bullous keratopathy (BK) is a pathological condition characterized by the presence of fluid-filled blisters or “bullae” on the cornea, which is the clear front surface of the eye. The main underlying factor leading to the formation…
LumiThera Receives $2.3M NIH Grant for Dry AMD Trial
LumiThera has been granted a small business innovative research (SBIR) phase 2 grant from the National Institute of Health (NIH), totaling up to $2.3 million in funding over a span of 2 years. This NIH/NEI grant is geared towards supporting…
What Is Endophthalmitis and How to Manage It
What Is Endophthalmitis? Endophthalmitis is a rare but serious eye condition that can lead to vision loss if not promptly treated. This infection targets the interior structures of the eye, causing inflammation and potential damage. Understanding the symptoms, causes, treatment…
What Is Bull’s Eye Maculopathy and How to Manage It
What Is Bull’s Eye Maculopathy? Bull’s Eye Maculopathy is a specific form of retinal disease characterized by changes in the pigmentation of the macular region of the retina, often presenting as a ‘bull’s eye’ pattern. The macula is the central…
Tenpoint Therapeutics Launches with $70M Financing
Tenpoint Therapeutics, a biotechnology company focused on vision-restoring engineered cell-based therapeutics and in vivo reprogramming for degenerative ocular diseases, has announced its launch with a $70 million Series A financing. The funding will be used to develop the company’s regenerative…
Naegis Pharma Funds Novel Eye Drug
Naegis Pharmaceuticals Inc., a life sciences company specializing in inflammation and ophthalmology, announced the successful closure of a financing round to advance its lead compound, N0651, towards a Phase 2 clinical trial. This funding will support the compound’s progression through…
Glaucoma Patients Miss Regular Eye Doctor Visits
In the August issue of Ophthalmology Epidemiology, a recently published study unveils a concerning trend among glaucoma patients. It was discovered that one-third of these patients ceased to visit their eye doctors for regular check-ups over a 10-year period. Conducted…
Glaucomatous Optic Neuropathy & Latest Treatments
Glaucomatous optic neuropathy is characterized by progressive loss of retinal ganglion cells (RGCs) and their axons and leads to measureable structural and functional damage to the optic nerve, visual impairment, and blindness. The primary site of injury is thought to be…
Pros and Cons of Laser Surgery for Glaucoma Patients
Glaucoma is a complex eye condition characterized by increased intraocular pressure, which can lead to damage to the optic nerve and vision loss if left untreated. This group of eye disorders often develops without noticeable symptoms in its early stages,…
Anterior Uveitis: Causes, Symptoms and Treatment
Picture this: You’re an astronaut on a space mission, and you’ve just stepped out of your spacecraft onto the surface of a mysterious new planet. Your eyesight is crucial to your survival in this alien environment, as you must rely…